These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3180007)

  • 1. Involvement of chromosomes 3 and 5 in renal cell carcinoma.
    Dal Cin P; Li FP; Prout GR; Huben RP; Limon J; Ferti-Passantonopoulou A; Richie JP; Sandberg AA
    Cancer Genet Cytogenet; 1988 Oct; 35(1):41-6. PubMed ID: 3180007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetics of tumor cells from patients with nonfamilial renal cell carcinomas.
    Sugao H; Seguchi T; Nakano E; Matsuda M; Sonoda T; Nakamura M; Goto T
    Urol Int; 1992; 48(2):138-43. PubMed ID: 1585507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific chromosome aberration in human renal cell carcinoma.
    Kovacs G; Szücs S; De Riese W; Baumgärtel H
    Int J Cancer; 1987 Aug; 40(2):171-8. PubMed ID: 3610386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent genomic rearrangements are not at the fragile sites on chromosomes 3 and 5 in human renal cell carcinomas.
    Kovacs G; Brusa P
    Hum Genet; 1988 Sep; 80(1):99-101. PubMed ID: 3417313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytogenetic studies of tumor tissue from patients with nonfamilial renal cell carcinoma.
    Yoshida MA; Ohyashiki K; Ochi H; Gibas Z; Pontes JE; Prout GR; Huben R; Sandberg AA
    Cancer Res; 1986 Apr; 46(4 Pt 2):2139-47. PubMed ID: 3948185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion 3p: the only chromosome loss in a primary renal cell carcinoma.
    Szücs S; Müller-Brechlin R; DeRiese W; Kovacs G
    Cancer Genet Cytogenet; 1987 Jun; 26(2):369-73. PubMed ID: 3567881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal chromosome abnormalities in tumor cells from patients with sporadic renal cell carcinomas.
    Kovacs G; Frisch S
    Cancer Res; 1989 Feb; 49(3):651-9. PubMed ID: 2910484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomal changes in renal cell carcinoma. No evidence for correlation with clinical stage.
    Teyssier JR; Ferre D
    Cancer Genet Cytogenet; 1990 Apr; 45(2):197-205. PubMed ID: 2317768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal cell carcinoma. Cytogenetic analysis of tumors and cell lines.
    Zhao WP; Gnarra JR; Liu S; Knutsen T; Linehan WM; Whang-Peng J
    Cancer Genet Cytogenet; 1995 Jul; 82(2):128-39. PubMed ID: 7664242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic defects in nonfamilial renal cell carcinoma. Possible specific chromosome change.
    Miles J; Michalski K; Kouba M; Weaver DJ
    Cancer Genet Cytogenet; 1988 Aug; 34(1):135-42. PubMed ID: 3395987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetics of 12 cases of renal adenocarcinoma.
    de Jong B; Oosterhuis JW; Idenburg VJ; Castedo SM; Dam A; Mensink HJ
    Cancer Genet Cytogenet; 1988 Jan; 30(1):53-61. PubMed ID: 3422048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chromosome analysis of renal cell carcinoma].
    Hata M; Baba S; Saito S; Tachibana M; Deguchi N; Jitsukawa S; Tazaki H
    Nihon Hinyokika Gakkai Zasshi; 1990 Sep; 81(9):1389-95. PubMed ID: 2232431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormalities at chromosome region 3p12-14 characterize clear cell renal carcinoma.
    Carroll PR; Murty VV; Reuter V; Jhanwar S; Fair WR; Whitmore WF; Chaganti RS
    Cancer Genet Cytogenet; 1987 Jun; 26(2):253-9. PubMed ID: 3471307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic abnormalities associated with renal cell carcinoma.
    Maloney KE; Norman RW; Lee CL; Millard OH; Welch JP
    J Urol; 1991 Sep; 146(3):692-6. PubMed ID: 1875474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rearrangements of chromosome 3 in nonfamilial renal cell carcinomas from Japanese patients.
    Yoshida MA; Ikeuchi T; Tachibana Y; Takagi K; Moriyama M; Tonomura A
    Jpn J Cancer Res; 1988 May; 79(5):600-7. PubMed ID: 3136112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific chromosome anomalies and predisposition to human breast, renal cell, and colorectal carcinoma.
    Pathak S; Goodacre A
    Cancer Genet Cytogenet; 1986 Jan; 19(1-2):29-36. PubMed ID: 3940177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetic and corresponding flow cytometric DNA analysis of renal cell neoplasms.
    el-Naggar AK; Pathak S
    Anticancer Res; 1992; 12(5):1491-500. PubMed ID: 1444211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3p involvement in a renal cell carcinoma in von Hippel-Lindau syndrome. Region of tumor breakpoint clustering on 3p?
    Decker HJ; Neumann HP; Walter TA; Sandberg AA
    Cancer Genet Cytogenet; 1988 Jul; 33(1):59-65. PubMed ID: 3164241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of common 3p14 fragile site expression in renal cell carcinoma with deletion breakpoint at 3p14.
    Tajara EH; Berger CS; Hecht BK; Gemmill RM; Sandberg AA; Hecht F
    Cancer Genet Cytogenet; 1988 Mar; 31(1):75-82. PubMed ID: 3125960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.